Erik Holmes Andrews, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
E2F4 Transcription Factor | 2 | 2016 | 32 | 0.260 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2017 | 857 | 0.250 |
Why?
|
Polyomavirus | 2 | 2014 | 234 | 0.210 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 239 | 0.150 |
Why?
|
Hematopoiesis | 2 | 2016 | 2047 | 0.130 |
Why?
|
E2F1 Transcription Factor | 1 | 2016 | 178 | 0.130 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2016 | 124 | 0.120 |
Why?
|
Smad2 Protein | 1 | 2014 | 145 | 0.120 |
Why?
|
Computational Biology | 2 | 2017 | 3502 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2016 | 8506 | 0.110 |
Why?
|
Liposarcoma | 1 | 2016 | 283 | 0.110 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 869 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1372 | 0.100 |
Why?
|
Transcription Factors | 3 | 2017 | 12096 | 0.090 |
Why?
|
User-Computer Interface | 1 | 2016 | 1397 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2751 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4711 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 577 | 0.080 |
Why?
|
Ovary | 1 | 2012 | 958 | 0.080 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 1055 | 0.080 |
Why?
|
Promoter Regions, Genetic | 3 | 2016 | 5779 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2012 | 989 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3362 | 0.060 |
Why?
|
Carcinoma | 1 | 2014 | 2330 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7590 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2014 | 3665 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5403 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 3599 | 0.040 |
Why?
|
DNA Methylation | 1 | 2012 | 4373 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3783 | 0.040 |
Why?
|
Apoptosis | 1 | 2014 | 9468 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2016 | 21017 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2012 | 4876 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11594 | 0.030 |
Why?
|
Prognosis | 4 | 2016 | 29558 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2016 | 16886 | 0.030 |
Why?
|
Base Sequence | 2 | 2012 | 12436 | 0.020 |
Why?
|
Lentivirus | 1 | 2014 | 503 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2012 | 869 | 0.020 |
Why?
|
Etoposide | 1 | 2012 | 630 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17768 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12440 | 0.020 |
Why?
|
HeLa Cells | 1 | 2016 | 3096 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1737 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17617 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9405 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 623 | 0.020 |
Why?
|
CpG Islands | 1 | 2012 | 1221 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1694 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2551 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1832 | 0.020 |
Why?
|
Mice | 4 | 2016 | 81107 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1740 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2012 | 2673 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9304 | 0.020 |
Why?
|
Neoplasms | 2 | 2012 | 22030 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2836 | 0.020 |
Why?
|
Algorithms | 2 | 2016 | 13959 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3261 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2012 | 9575 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6493 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 2100 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3082 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3615 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3384 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10112 | 0.010 |
Why?
|
Humans | 9 | 2019 | 758381 | 0.010 |
Why?
|
Animals | 4 | 2016 | 167777 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12721 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15594 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9312 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23883 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39873 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12945 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7338 | 0.010 |
Why?
|
Female | 4 | 2019 | 390316 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58681 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15773 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64379 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 73806 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 80170 | 0.010 |
Why?
|
Aged | 1 | 2019 | 168217 | 0.000 |
Why?
|
Middle Aged | 1 | 2019 | 219560 | 0.000 |
Why?
|
Male | 1 | 2019 | 358742 | 0.000 |
Why?
|